Safety and efficacy of Danqipiantan capsule for treatment of stroke: a systematic review

£5.50
VAT Exempt
In stock
SKU
JTCM-484
Reward Points With this product, you earn 6 loyalty points.

To read the full abstract subscribe to the JCM online archive

Danqipiantan capsule (DQPTC) is a drug that has been recently licensed for the treatment of stroke in China. This review of the safety and efficacy of DQPTC for the ...
More Information
Author Li Jiashen
Write Your Own Review
You're reviewing:Safety and efficacy of Danqipiantan capsule for treatment of stroke: a systematic review
Your Rating

* Orders shipped outside of Europe are eligible for VAT relief and will not be charged VAT.